Apply for funding to undertake implementation research to understand the optimal strategies for roll-out and scale up of the malaria vaccines RTS,S and R21 to ensure that they are deployed in the most effective and equitable way for population health benefit. Research should be conducted in at least two Sub-Saharan African countries, one of which should have a high malaria burden. Applications of all sizes will be funded, including large research projects and small to medium-scale applications.
You must firstly submit a pre-application to apply for this funding opportunity. Following MRC confirmation your project is within remit, you will be invited to submit a full application.
Eligibility: To be eligible to apply for this opportunity you must be:
- be eligible as an individual
- be based at either an eligible UK research organisation, or based in a:
- research organisation in a low or middle-income country (LMIC), with degree-awarding powers recognised by the government in which the organisation is based
- research-focused institute based in an LMIC either funded by the government of the country in which the organisation is based, or by a not-for-profit organisation
- research-focused not-for-profit organisation based in an LMIC with dedicated research capacity
Level of funding: 80% of full economic cost will be funded, with the exception of eligible international costs, which are funded at 100%
Key dates
- 03 June 2024: applications close at 16:00 BST